 |
Enbrel is used to treat rheumatoid arthritis. ( ) |
Drug nets $284m for MGH
Foreign royalty sale is second Enbrel windfall
Massachusetts General Hospital yesterday sold its rights to royalties on foreign sales of the rheumatoid arthritis drug Enbrel for $284 million, a move that eliminates its exposure to market risk and will help it build a research endowment. (Full article: 456 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
